Millennium Management’s Wave Life Sciences WVE Stock Holding History

Millennium Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,000	Closed	-$732K	–	6525
2025 Q3	$732K	Buy	+100,000	New	+$809K	﹤0.01%	4846
2021 Q3	–	Sell	-123,200	Closed	-$821K	–	7319
2021 Q2	$821K	Buy	123,200 +73,200	+146%	+$478K	﹤0.01%	4856
2021 Q1	$281K	Buy	+50,000	New	+$480K	﹤0.01%	5260
2020 Q1	–	Sell	-20,500	Closed	-$164K	–	4571
2019 Q4	$164K	Buy	20,500 +2,200	+12%	+$53.9K	﹤0.01%	3922
2019 Q3	$375K	Buy	+18,300	New	+$420K	﹤0.01%	3439

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Millennium Management's WVE Position: Q1 2026 in Review

Millennium Management increased its Wave Life Sciences (WVE) stake by 66% in Q1 2026, buying an estimated $5.05M and bringing the position to 972,241 shares worth $7.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

Millennium Management first reported a position in WVE in Q2 2017 and has held it in 33 quarters since. The position peaked at $14.6M in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Millennium Management held 972,241 shares of Wave Life Sciences worth $7.05M as of Q1 2026.
Millennium Management bought 387,608 Wave Life Sciences shares in Q1 2026, an estimated $5.05M.
Wave Life Sciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2558 holding.
Millennium Management first reported a position in Wave Life Sciences in Q2 2017 and has held it in 33 quarters since.
Millennium Management's Wave Life Sciences position peaked at $14.6M in Q4 2024.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.